XO Life has created a globally unique meta-platform, the ImpactMonitor™ platform, for digital product and therapy support for patients. Patients are accompanied during their product application or therapy with verified medical and health-relevant content, record their health and therapy progress, receive personalized insights and medical support from experts and can exchange information with other patients.
Manufacturers create their own product and therapy areas on the ImpactMonitor
ImpactMonitor™ platform and offer them to their patients with their own branding, content, questions and services. By providing personalized information and continuous support during treatment, manufacturers make an important contribution to the success of treatment, treatment adherence and application safety for patients.
XO Life is one of the great hopes in the healthcare sector and is one of the leading digital health start-ups in Germany and Europe. In March 2023, XO Life was nominated for the Digital Award by the Federal Ministry of Economics and Climate Protection as one of 10 start-ups from various sectors of the economy.
XO Life works with global market leaders, SMEs and rare disease manufacturers in more than 30 indications. User engagement on the platform is 10x higher than the average digital health app and last year alone over 120,000 medical questions were answered by patients. The ImpactMonitor™ platform is now available in all European countries and languages.
